Prof Dike Ojji of UNIABUJA Presents Veronica Trial Results at ESC Congress 2024
Prof Dike Ojji of the University of Abuja shared key findings from the Veronica Trial during the European Society of Cardiology Congress in London on August 31, 2024.
Mary Nwaeze 
Professor Dike Ojji, Lead Investigator of the Cardiovascular Research Unit at the University of Abuja and University of Abuja Teaching Hospital, Gwagwalada, Abuja, showcased groundbreaking findings during the 2024 European Society of Cardiology (ESC) Congress. Held in the prestigious Main Auditorium of the London Convention Center, Professor Ojji presented the results of the highly anticipated Veronica Trial as part of the congress's Hotline Session II.
The event, which took place on Saturday, August 31, 2024, drew global attention as Professor Ojji detailed the outcomes of the Veronica Trial, a major study in cardiovascular health. This presentation highlighted key advancements in hypertension treatment, providing hope for patients suffering from heart conditions.
The Veronica Trial is expected to shape the future of cardiovascular medicine and further solidify the University of Abuja’s position as a leader in medical research.
Follow Myschoolnews.ng for more updates from UNIABUJA.
